Breast Cancer Clinical Trial
Official title:
Psychosocial Outcomes in Online Cancer Support Groups
Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women
with breast cancer differ based on the format of online group support. This objective will
be addressed by the following specific aims:
1. Specific Aim #1 is to determine if there is a difference in depressive symptoms between
women with breast cancer assigned to one of two treatment conditions: moderated online
support or peer-led online support.
• H1: Women with breast cancer who participate in moderated online support will report
fewer depressive symptoms than women with breast cancer in peer led online support.
2. Specific Aim #2 is to determine if there is a difference in perceived social support
between women with breast cancer who are assigned to one of two treatment conditions:
moderated online support or peer-led online support.
• H2: Women with breast cancer who participate in moderated online support will report
greater perceived social support than women with breast cancer in peer-led online
support.
3. Specific Aim #3 is to determine if there is a difference in quality of life in women
with breast cancer who are assigned to one of two treatment conditions: moderated
online support or peer-led online support.
- H3: Women with breast cancer who participate in moderated online support will
report better quality of life than women with breast cancer in peer-led online
support.
NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a
support group, if that was her choice. We also could not control if participants joined a
second online support group or face-to-face group during the study. Therefore, we decided to
omit a "usual care" (no support) group. The study was completed with just two groups:
moderated and peer-support.
Purpose/Specific Aims: The purpose of this randomized two-group longitudinal study is to
evaluate whether psychosocial outcomes in women with breast cancer differ based on the
format of online group support. Rationale/Significance of study: No research has explored
differences in psychosocial outcomes between online support groups that use a professional
moderator and those that use a peer-led (self-help) format. This study will address one of
the goals put forth in the 2003-2005 ONS Research Agenda, by studying the effects of
technology based interventions (online support) on psychosocial outcomes (depression,
perceived social support, quality of life) in women with breast cancer. This work will add
to the nursing research base with regard to online support for women with breast cancer and
provide a springboard for additional studies to enhance the research base. Conceptual
Framework: The concept of openness, based on the mutual interaction between human beings and
their environment, and emphasized in Rogers' Science of Unitary Human Beings provides a
basis for this project. The research will utilize two different support environments and
measure how interactions in each affect psychosocial outcomes over time. Main Research
Variables: The independent variables are two treatment conditions (moderated online support,
peer-led online support). The dependent variables are depressive symptoms, perceived social
support, and quality of life. Design: A randomized longitudinal design, comparing two types
of online support groups, on the basis of three principal measures, will be used. Each
measure will be obtained at baseline and at three later timepoints. Setting: Support groups
will be accessed from secure and password protected university web pages devoted exclusively
to this study. Sample: Sixty women with breast cancer, at least 21 years of age, who have
Internet access will be recruited. Methods: Women will be randomly assigned to one of the
two treatment conditions (moderated online support, peer-led online support) given a
password, and instructed to complete a Demographic Form and the study questionnaires online.
All subjects will be asked to complete the study questionnaires again at 6, 12, and 16
weeks. Moderated groups will run in a semi-structured format over 12 weeks, with a different
discussion topic moderated each week by the moderator. Peer-led groups will be run in a peer
support format over 12 weeks. Implications for practice: Women with breast cancer are
turning to online resources for support. Nurses should be aware of the benefits/limitations
of this support alternative. A cost benefit may be suggested if it is shown that peer-led
online support has psychosocial benefits similar to professionally facilitated groups.
Additional research is needed to explore the impact of online support on psychosocial
outcomes in people with other cancers, minorities, and men. This study will add important
information to the research base regarding online support groups and help determine the best
strategy for online cancer support.
NOTE: It was obvious that we could not prevent anyone from joining a support group, if that
was her choice. We also could not control if participants joined a second online support
group or face-to-face group during the study. Therefore, we dropped the "usual care" (no
support) group. The study was completed with just two groups: moderated and peer-support.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |